How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway
European Journal of Internal Medicine · 2023
DOI: 10.1016/j.ejim.2023.06.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Internal Medicine, 2023. Verfasst von Bénédicte Delcoigne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Electronic address: benedicte.delcoigne@ki.se. Hauptthemen laut MEDLINE: Antirheumatic Agents, Acute Coronary Syndrome, Arthritis, Rheumatoid. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVES: To estimate short-term risks of acute coronary syndrome (ACS) in patients with rheumatoid arthritis (RA) as a function of current RA disease activity including remission. METHODS: Data from clinical visits of RA patients in Sweden (SE) and Norway (NO) between January 1st 2012 until December 31st 2020 were used. At each visit, patient's disease activity was assessed including remission status (measured with several metrics). Through linkage to national health and death registers, patients were followed up for incident ACS up to six months from each visit. We compared the short-term risk of ACS in patients not in remission vs. in remission using Cox regression analyses with robust standard errors, adjusted for country and covariates (e.g., age, sex, prednisolone use, comorbidities). We also explored disease activity categories as exposure. RESULTS: We included 212,493 visits (10,444 from Norway and 202,049 from Sweden) among 41,250 patients (72% women, mean age at visit 62 years). During the 6-month follow-ups, we observed 524 incident ACS events. Compared to patients in remission, patients currently not in remission had an increased rate of ACS: adjusted hazard ratio (95% confidence interval) 1.52 (1.24-1.85) with DAS28 metric. The crude absolute six-month risks were 0.2% for patients in remission vs. 0.4% for patients with DAS28 high disease activity. The use of alternative RA disease activity and remission metrics provided similar results. CONCLUSION: Failure to reach remission is associated with elevated short-term risks of ACS, underscoring the need for CV risk factor optimization in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Electronic address: benedicte.delcoigne@ki.se.
- Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.
- Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Rheumatology, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm Sweden.
- Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden.
Zitieren
APA
Delcoigne, B., Provan, S. A., Kristianslund, E. K., Askling, J., & Ljung, L. (2023). How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2023.06.013
Vancouver
Delcoigne B, Provan SA, Kristianslund EK, Askling J, Ljung L. How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway. European Journal of Internal Medicine. 2023. doi:10.1016/j.ejim.2023.06.013
BibTeX
@article{Delcoigne2023,
author = {Delcoigne, Bénédicte and Provan, Sella A and Kristianslund, Eirik K and Askling, Johan and Ljung, Lotta},
title = {How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway},
journal = {European Journal of Internal Medicine},
year = {2023},
doi = {10.1016/j.ejim.2023.06.013}
}
EUVIMED